|
Destiny Pharma PLC - a clinical-stage biotechnology company based in Brighton, England - Raises total gross proceeds of £450,000 through its open offer. Has conditionally raised total gross proceeds of £6.5 million through its placing, subscription, and open offer. Says it has applied for the admission of 12.9 million shares, consisting of 11.9 million placing shares, 140,000 subscription shares and 909,007 open offer shares.
Destiny Pharma said earlier this month that it intends to raise £7.0 million through a placing of 11.9 million shares at 50 pence each, a subscription for 140,000 shares and an open offer for 2.0 million shares.
Current stock price: 50.67 pence
12-month change: down 65%
Copyright 2022 Alliance News Limited. All Rights Reserved.
|
